COPENHAGEN, Denmark, May 5, 2025 /PRNewswire/ — Dawn Health, a global leader in digital health, has secured a funding round of €11.5 million from its existing investors: Chr. Augustinus Fabrikker, the Export and Investment Fund of Denmark (EIFO), and Trifork. The investment is aimed at supporting the company’s strategy to deliver its platform and product suite to global pharma companies through a SaaS model, while continuing to invest in further offerings within the Dawn Product Suite.

Since 2021, Dawn Health has been dedicated to developing a best-in-class platform designed specifically to accommodate the needs and use cases of the pharmaceutical industry. The Dawn Platform and Product Suite have already been widely adopted by five global industry leaders, including Merck and Novartis. The Dawn Platform is currently used in areas such as oncology, multiple sclerosis, and rare pediatric conditions like growth disorders. It helps patients manage their treatment, report symptoms, and stay in close contact with their healthcare team.

The Dawn Platform and Product Suite empower pharma companies, patients, and healthcare professionals to improve outcomes and patient care by leveraging advanced capabilities in AI, data, evidence generation, clinical integrations, personalization, and connected health. By improving both data collection and analytics, these capabilities ultimately benefit patients and pharma companies alike, positioning the Dawn Platform as the foundation for therapy companions, disease management programs, and real-world evidence (RWE) solutions that enable the next generation of digital health.

“Our ambition is to be the global leader in digital health, powering pharma’s next-generation products – and ultimately improving the lives of patients worldwide,” said Alexander Mandix Hansen, CEO of Dawn Health. “This funding allows us to bring our proven platform to more markets and deepen our impact.”

This next phase reinforces Dawn Health’s position as a trusted partner to pharma companies, delivering valuable, scalable, regulatory-grade digital health products that evolve with the needs of modern medicine.

“Since the major investment in December 2021, Dawn Health has grown its revenue significantly and expanded its footprint in global pharma. With more than 100 employees, unique solutions, and a strong regulatory infrastructure, we are prepared to further accelerate our growth,” says Chairman Lars Marcher.

About Dawn Health

Dawn Health is a global leader in digital health, specializing in the development of Software as a Medical Device (SaMD), Digital Therapeutics (DTx), and connected health solutions. Accelerating the launch of digital solutions to market, the Dawn Health product suite drives innovation to change the lives of people with chronic conditions. Through close partnerships with the life sciences industry, Dawn Health creates digital health products that transform patient care through an empathetic and human-centric approach.

www.dawnhealth.com

Logo – https://mma.prnewswire.com/media/2678720/Dawn_Health_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/dawn-health-secures-11-5-million-to-scale-platform–product-suite-for-next-gen-pharma-digital-health-solutions-302445153.html

TCN, a cloud-based call centre technology provider, announces further advances to Workforce Optimisation offerings.

LONDON and MIDLANDS, England and BUCHAREST, Romania and ST. GEORGE, Utah, May 5, 2025 /PRNewswire/ — TCN, a leading provider of cloud-based contact centre solutions, today announced the latest advancements and key features of its Workforce Optimisation (WFO) solution.

Designed to enhance contact centre performance, TCN’s WFO tool provides comprehensive insights into agent activities, empowering businesses to achieve their goals and foster a collaborative culture.

TCN designed WFO to enhance contact centre performance by providing insights into all agent activities. Contact centre managers need prompt alerts when predefined thresholds are met through key performance indicators, and WFO provides this. When conversations are flagged for review, agents will be given training and learning opportunities, helping them deliver a better experience.

“At TCN, our latest advancements in the workforce optimization application are not just about agent efficiency; they’re about empowering managers and agents with intuitive tools and deeper insights, ultimately leading to better outcomes, more meaningful customer interactions and a more engaged workforce,” said Scott Brownlee, director of product training and customer engagement.

Key Features and Advancements Include:

Comprehensive Insights: The system monitors Key Performance Indicators (KPIs) and delivers alerts when agents exceed predefined thresholds. This keeps everyone focused on goals and fosters a collaborative environment.Risk Evaluation: TCN’s WFO utilizes incident flagging and a query engine to flag compliance risks during agent conversations. Managers are promptly notified of flagged risks, enabling them to take immediate action and enact preventative measures for future compliance risks.Training and Learning Opportunities: WFO analyzes agents at work and creates learning opportunities based on individual agents’ strengths and weaknesses. Agents can access learning opportunities and complete tasks to improve their service. This includes new training and reviewing instances of compliance risks.Detailed Reporting: With built-in reporting, managers can receive detailed reports regarding agent and contact centre data, helping to identify areas of risk and improvement.Efficiency Improvements: Managers can implement custom KPIs and structure evaluations into focus areas for each agent. The KPIs enable greater focus on various areas and are supported by insight-driven dashboards.

TCN’s Workforce Optimisation tool equips contact centres with the tools to optimise agent performance, mitigate risks and drive overall efficiency. Visit TCN’s Workforce Optimization product page to learn more.

About TCN
TCN is a global leader in cloud-based contact centre solutions for accounts receivable management (ARM), healthcare providers, enterprises, contact centres and BPOs. TCN’s comprehensive suite includes omnichannel solutions, automation, predictive dialers, IVR, Click2Pay, compliance solutions and real-time analytics, driving operational efficiency and customer satisfaction.

TCN promises immediate access to the latest TCN Operator platform, facilitating seamless scalability. With a commitment to excellence and a dedication to meet evolving business needs from start to finish through industry-leading customer service, TCN continues to redefine the contact centre landscape. For further details, visit www.tcn.com.

Logo – https://mma.prnewswire.com/media/2595004/TCN_Logo_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/tcns-ai-enhanced-workforce-optimisation-drives-improved-contact-centre-performance-302445484.html

• Developed by top 1% scientists in the world from MIT
• Clinically proven: 90% less hair loss in 7 days, 140% volume boost after one use
• 100% vegan, Dermatest-certified, and eco-packaged

PARIS, May 5, 2025 /PRNewswire/ — ‘Grabity,’ a K-beauty hair loss brand developed by top scientists from MIT and KAIST’s Professor Haeshin Lee, has officially entered the European market after making waves at the FOIRE DE PARIS 2025, France’s largest consumer goods expo.

Since its debut in Korea a year ago, Grabity has sold over 1 million bottles and earned 20 billion KRW. It became a viral hit at retailers like Olive Young, where it sold out in just 39 minutes, creating “open run” lines. Now expanding into global markets—including Japan, the U.S., Taiwan, and the UAE—Grabity introduced itself to European consumers for the first time at the Paris event.

Held from April 30 to May 13 at PARIS PORTE DE VERSAILLES, FOIRE DE PARIS is a 120-year-old expo expected to attract over 450,000 visitors. Grabity’s booth saw overwhelming interest, with all 5,000 units prepared for the opening day fully exhausted shortly.

The brand presented its signature Hair Lifting Shampoo and new Hair Lifting Shot, highlighting its dual action: preventing hair loss and enhancing volume. Live demos of the brand’s LiftMax308™ technology impressed visitors, showing how it transforms fine, weak hair into thicker, fuller strands.

LiftMax308™, a patented polyphenol-based complex, protects the hair cortex, guards against heat and UV damage, and creates a lifting effect. Published research in Advanced Materials Interfaces confirmed a 90% reduction in hair loss within one week and a 140% improvement in hair volume after just one use.

Grabity’s formulas are 100% vegan, and certified “Excellent” for skin safety by Germany’s Dermatest. In line with European eco-values, its packaging uses recycled coconut shells to reduce plastic waste.

“At Grabity, we deliver results backed by science,” said CEO Haeshin Lee, also a Distinguished Professor at KAIST. “The Paris expo showed us that Korean innovation truly resonates with European consumers.”

About Polyphenol Factory
Founded in 2023 by faculty members of KAIST, Polyphenol Factory is a research-driven startup commercializing cutting-edge polyphenol technologies derived from nature. With a mission to “innovate everyday life through science,” the company is leading a new wave of global lifestyle transformation.

Website: Grabity
Contact: Anna Lee, yimijin@gmail.com

Photo – https://mma.prnewswire.com/media/2679065/iMAGE1.jpg
Photo – https://mma.prnewswire.com/media/2679066/iMAGE2.jpg

View original content:https://www.prnewswire.co.uk/news-releases/sensationally-hit-k-beauty-hair-loss-shampoo-grabity-shampoo-takes-europe-by-storm-302445516.html